• Accelerating TB vaccine Research & Development through partnership
  • TBVI TBVI TBVI
    • Home
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Steering Committee
        • Operational Office
        • Product and Clinical Development Team
        • Portfolio Management Committee
      • TBVI consortium
      • Key achievements and impact
      • Financials
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • For partners
      • For researchers and vaccine developers
        • Partners pages
        • Become a TBVI partner
        • Access to services
        • Conferences, meetings and workshops
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project overview and achievements
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 other publications
      • MTBVAC in Newborns
        • MTBVAC in newborns
        • Coordinator and partners
        • News and Publications
        • Communication tools
      • For funders
        • TBVI R&D priorities and funding opportunities
        • TBVI service provision and funding opportunities
        • Why invest in TBVI
    • News
    • Contact us:

    TBVAC2020 other publications

    Home / For partners / TBVAC2020 / TBVAC2020 other publications

    Annual meetings:

    • 2016 https://horizon2020projects.com/sc-health/tb-vaccine-rd-accelerated-through-partnership/
    • 2017 https://www.tbvi.eu/overview-tbvac-2020-annual-meeting-tbvi-annual-symposium/
    • 2018 https://www.tbvi.eu/2018-tbvi-symposium-tbvac2020-annual-meeting-les-diablerets-switzerland/
    • 2019 https://www.tbvi.eu/2019-tbvi-symposium-tb-vaccines-global-collaboration-and-recent-advances-in-the-field/

    Other:

    January 2015, article about TBVI being awarded a €24m EC grant to progress the TBVAC2020 project.

    For partners
    • For researchers and vaccine developers
    • TBVAC2020
      • Word from the chair
      • TBVAC2020 project overview and achievements
      • TBVAC2020 project members
      • TBVAC2020 scientific publications
      • TBVAC2020 other publications
    • MTBVAC in Newborns
    • For funders
    Menu
    • Home
    • About us
    • What we do
    • How we work
    • For researchers and vaccine developers
    • For funders
    • Pipeline of vaccines
    • News
    TuBerculosis Vaccine Initiative (TBVI)

    Runderweg 6
    8219 PK Lelystad
    The Netherlands
    Email: info@tbvi.eu
    Phone: +31 320 277 550

    © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

    Start typing and press Enter to search

    Cookies

    This website uses cookies that help the website function

    OK No